BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 26114478)

  • 21. Clinicopathological characteristics of oestrogen receptor negative, progesterone receptor positive breast cancers: re-evaluating subsets within this group.
    Ahmed SS; Thike AA; Zhang K; Lim JC; Tan PH
    J Clin Pathol; 2017 Apr; 70(4):320-326. PubMed ID: 27612503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroendocrine carcinomas of the breast.
    Rovera F; Masciocchi P; Coglitore A; La Rosa S; Dionigi G; Marelli M; Boni L; Dionigi R
    Int J Surg; 2008; 6 Suppl 1():S113-5. PubMed ID: 19167937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
    Bae SY; Kim S; Lee JH; Lee HC; Lee SK; Kil WH; Kim SW; Lee JE; Nam SJ
    BMC Cancer; 2015 Mar; 15():138. PubMed ID: 25880075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women.
    Sapino A; Righi L; Cassoni P; Papotti M; Gugliotta P; Bussolati G
    Mod Pathol; 2001 Aug; 14(8):768-76. PubMed ID: 11504836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical features and treatment response of solid neuroendocrine breast carcinoma to adjuvant chemotherapy and endocrine therapy.
    Zhu Y; Li Q; Gao J; He Z; Sun R; Shen G; Zhang H; Xia W; Xu J
    Breast J; 2013; 19(4):382-7. PubMed ID: 23721399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double neuroendocrine ductal carcinomas in situ coexisting with a background of diffuse idiopathic neuroendocrine cell hyperplasia of breast: a case report and hypothesis of neuroendocrine tumor development.
    Miura K; Nasu H; Ogura H
    Pathol Int; 2012 May; 62(5):331-4. PubMed ID: 22524661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical study of neuroendocrine differentiation in primary glandular lesions and tumors of the urinary bladder.
    Bollito ER; Pacchioni D; Lopez-Beltran A; Volante M; Terrone C; Casetta G; Mari M; DePompa R; Cappia S; Papotti M
    Anal Quant Cytol Histol; 2005 Aug; 27(4):218-24. PubMed ID: 16220833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The genetic landscape of breast carcinomas with neuroendocrine differentiation.
    Marchiò C; Geyer FC; Ng CK; Piscuoglio S; De Filippo MR; Cupo M; Schultheis AM; Lim RS; Burke KA; Guerini-Rocco E; Papotti M; Norton L; Sapino A; Weigelt B; Reis-Filho JS
    J Pathol; 2017 Feb; 241(3):405-419. PubMed ID: 27925203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of pathologic complete response and Ki67 expression after neoadjuvant chemotherapy in breast cancer.
    Yoshioka T; Hosoda M; Yamamoto M; Taguchi K; Hatanaka KC; Takakuwa E; Hatanaka Y; Matsuno Y; Yamashita H
    Breast Cancer; 2015 Mar; 22(2):185-91. PubMed ID: 23645542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ki67 expression in breast cancer. Correlation with prognostic markers and clinicopathological parameters in Saudi patients.
    Elkablawy MA; Albasri AM; Mohammed RA; Hussainy AS; Nouh MM; Alhujaily AS
    Saudi Med J; 2016 Feb; 37(2):137-41. PubMed ID: 26837394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Invasive mammary carcinoma with neuroendocrine differentiation: histological features and diagnostic challenges.
    Tang F; Wei B; Tian Z; Gilcrease MZ; Huo L; Albarracin CT; Resetkova E; Zhang H; Sahin A; Chen J; Bu H; Abraham S; Wu Y
    Histopathology; 2011 Jul; 59(1):106-15. PubMed ID: 21668471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. INSM1 is a novel prognostic neuroendocrine marker for luminal B breast cancer.
    Razvi H; Tsang JY; Poon IK; Chan SK; Cheung SY; Shea KH; Tse GM
    Pathology; 2021 Feb; 53(2):170-178. PubMed ID: 32951906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroendocrine ductal carcinoma in situ (NE-DCIS) of the breast--comparative clinicopathological study of 20 NE-DCIS cases and 274 non-NE-DCIS cases.
    Kawasaki T; Nakamura S; Sakamoto G; Murata S; Tsunoda-Shimizu H; Suzuki K; Takahashi O; Nakazawa T; Kondo T; Katoh R
    Histopathology; 2008 Sep; 53(3):288-98. PubMed ID: 18657193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroendocrine breast cancer: retrospective analysis of 96 patients and review of literature.
    Rovera F; Lavazza M; La Rosa S; Fachinetti A; Chiappa C; Marelli M; Sessa F; Giardina G; Gueli R; Dionigi G; Rausei S; Boni L; Dionigi R
    Int J Surg; 2013; 11 Suppl 1():S79-83. PubMed ID: 24380560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Solid papillary carcinoma of the breast: A special entity needs to be distinguished from conventional invasive carcinoma avoiding over-treatment.
    Guo S; Wang Y; Rohr J; Fan C; Li Q; Li X; Wang Z
    Breast; 2016 Apr; 26():67-72. PubMed ID: 27017244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroendocrine differentiation and prognosis in breast adenocarcinoma.
    Miremadi A; Pinder SE; Lee AH; Bell JA; Paish EC; Wencyk P; Elston CW; Nicholson RI; Blamey RW; Robertson JF; Ellis IO
    Histopathology; 2002 Mar; 40(3):215-22. PubMed ID: 11895486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High Ki67/BCL2 index is associated with worse outcome in early stage breast cancer.
    Min KW; Kim DH; Do SI; Pyo JS; Chae SW; Sohn JH; Kim K; Lee HJ; Kim DH; Oh S; Choi SH; Park YL; Park CH; Kwon MJ; Moon KM
    Postgrad Med J; 2016 Dec; 92(1094):707-714. PubMed ID: 27222586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical expression and prognostic value of ER, PR and HER2/neu in pancreatic and small intestinal neuroendocrine tumors.
    Arnason T; Sapp HL; Barnes PJ; Drewniak M; Abdolell M; Rayson D
    Neuroendocrinology; 2011; 93(4):249-58. PubMed ID: 21487213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nuclear Insulinoma-Associated Protein 1 Expression as a Marker of Neuroendocrine Differentiation in Neoplasms of the Breast.
    Seijnhaeve E; Galant C; Van Bockstal MR
    Int J Surg Pathol; 2021 Aug; 29(5):496-502. PubMed ID: 33426999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mucinous carcinoma of the breast: a comparative study on cytohistological findings associated with neuroendocrine differentiation.
    Ohashi R; Sakatani T; Matsubara M; Watarai Y; Yanagihara K; Yamashita K; Tsuchiya S; Takei H; Naito Z
    Cytopathology; 2016 Jun; 27(3):193-200. PubMed ID: 26804749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.